Search

Your search keyword '"Lubetzki, Catherine"' showing total 686 results

Search Constraints

Start Over You searched for: Author "Lubetzki, Catherine" Remove constraint Author: "Lubetzki, Catherine"
686 results on '"Lubetzki, Catherine"'

Search Results

2. Cerebellar encephalitis and peripheral neuropathy with an atypical clinical and neuroimaging signature following Covid-19 vaccine: a report of two cases

4. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

5. Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study

6. Neuro-Psychological Outcome of ICU-Admitted COVID-19 Patients Presenting With CNS Complications

7. Genetically modified macrophages accelerate myelin repair

9. Aquaporin 4 distribution in the brain and its relevance for the radiological appearance of neuromyelitis optica spectrum disease

11. Neuronal activity promotes axonal node-like clustering prior to myelination and remyelination in the central nervous system

14. Functional Characterization of DNA Methylation in the Oligodendrocyte Lineage.

16. Increased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic Models

19. Frequent detection of IFN-gamma-producing memory effector and effector T cells in patients with progressive multifocal leukoencephalopathy.

20. Clinical correlates of respiratory disorders in patients with severe multiple sclerosis: A cross-sectional cohort.

29. Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis

31. The radiologically isolated syndrome: revised diagnostic criteria

33. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

42. A multicentre, open label, single-arm, phase 3b study (CONSONANCE) to assess the effectiveness and safety of ocrelizumab in patients with primary and secondary progressive multiple sclerosis: year-1 interim analysis (P1-1.Virtual)

43. A multicenter, open label, single-arm, phase 3b study (CONSONANCE) to assess efficacy of ocrelizumab in patients with primary and secondary progressive multiple sclerosis: year 1 interim analysis of cognition outcomes (P1-1.Virtual)

44. Recurrence of severe symptomatic late-onset neutropenia on ocrelizumab.

46. Genetically modified macrophages accelerate myelin repair

47. Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal

48. Alterations of the axon initial segment in multiple sclerosis

49. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

50. Imaging of CNS Myelin by Positronemission Tomography

Catalog

Books, media, physical & digital resources